EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Insulin Resistance in Mitochondrial Diabetes

Chika Takano iD, Erika Ogawa, Satoshi Hayakawa iD

Biomolecules · 07.01.2023 · 13 (1) · 126

DOI: 10.3390/biom13010126 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 07.01.2023. Verfasst von Chika Takano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo 173-8610, Japan. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial diabetes (MD) is generally classified as a genetic defect of β-cells. The main pathophysiology is insulin secretion failure in pancreatic β-cells due to impaired mitochondrial ATP production. However, several reports have mentioned the presence of insulin resistance (IR) as a clinical feature of MD. As mitochondrial dysfunction is one of the important factors causing IR, we need to focus on IR as another pathophysiology of MD. In this special issue, we first briefly summarized the insulin signaling and molecular mechanisms of IR. Second, we overviewed currently confirmed pathogenic mitochondrial DNA (mtDNA) mutations from the MITOMAP database. The variants causing diabetes were mostly point mutations in the transfer RNA (tRNA) of the mitochondrial genome. Third, we focused on these variants leading to the recently described “tRNA modopathies” and reviewed the clinical features of patients with diabetes. Finally, we discussed the pathophysiology of MD caused by mtDNA mutations and explored the possible mechanism underlying the development of IR. This review should be beneficial to all clinicians involved in diagnostics and therapeutics related to diabetes and mitochondrial diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes MellitusHumansInsulinMitochondriaDNA, MitochondrialMutation

Stichwörter der Autor:innen

insulin resistancemitochondrial DNA mutationmitochondrial diabetestransfer RNA modopathy

Substanzen

InsulinDNA, Mitochondrial

Autor:innen und Institutionen

  • Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo 173-8610, Japan.
  • Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo 173-8610, Japan.
  • Department of Pediatrics, Tokyo Metropolitan Hiroo Hospital, Tokyo 150-0013, Japan.

ORCID-Profile: Chika Takano, Satoshi Hayakawa

Förderung

  • Japan Society for the Promotion of Science KAKENHI

Zitieren

APA

Takano, C., Ogawa, E., & Hayakawa, S. (2023). Insulin Resistance in Mitochondrial Diabetes. Biomolecules, 13(1), 126. https://doi.org/10.3390/biom13010126

Vancouver

Takano C, Ogawa E, Hayakawa S. Insulin Resistance in Mitochondrial Diabetes. Biomolecules. 2023;13(1):126. doi:10.3390/biom13010126

BibTeX
@article{Takano2023,
  author = {Takano, Chika and Ogawa, Erika and Hayakawa, Satoshi},
  title = {Insulin Resistance in Mitochondrial Diabetes},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {1},
  pages = {126},
  doi = {10.3390/biom13010126}
}
Kostenlos starten →